SCHEMBL15536327

SCHEMBL15536327

O=[N+]([O-])c1c(Cl)cccc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIN1 Q13526 2/20 0.50
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ HPGD P15428 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ MITF O75030 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ XBP1 P17861 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ RXRA P19793 1/20 0.49
▸ RXRB P28702 1/20 0.49
▸ HTR1A P08908 2/20 0.48
▸ ADRA1D P25100 2/20 0.48
▸ ADRA1A P35348 2/20 0.48
▸ ADRA1B P35368 2/20 0.48
▸ MAPT P10636 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15013285 0.89 MAPT (0.55) MEN1KMT2ANPC1HTR1AADRA1D
SCHEMBL9528862 0.83 HTR1A (0.54) PIN1MEN1KMT2ANPC1RAB9A
SCHEMBL29617906 0.82 HPD (0.52) MEN1KMT2ANPC1HTR1AADRA1D
SCHEMBL30318898 0.82 HPD (0.49) MEN1KMT2AHTR1AADRA1DADRA1A
SCHEMBL1708309 0.82 MGMT (0.53) MEN1KMT2AHTR1AADRA1DADRA1A
SCHEMBL29617955 0.82 MAPT (0.47) MEN1KMT2ANPC1HTR1AADRA1D
SCHEMBL2892659 0.82 HPD (0.52) MEN1KMT2ANPC1HTR1AADRA1D
SCHEMBL647866 0.82 TDP1 (0.56) MEN1KMT2ARXRARXRBHTR1A
SCHEMBL1121791 0.82 HPD (0.49) MEN1KMT2AHTR1AADRA1DADRA1A
SCHEMBL28231949 0.82 HPD (0.51) PIN1MEN1KMT2ANPC1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017062581-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR PROTEOSTASIS THERAPEUTICS, INC. (US) 2017-04-13 — — WO disclosed
EP-2852572-A1 CARBOLINE AND CARBAZOLE BASED IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION Eli Lilly and Company (US) 2015-04-01 — — EP disclosed
WO-2013176698-A1 CARBOLINE AND CARBAZOLE BASED IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION ELI LILLY AND COMPANY (US) 2013-11-28 — — WO disclosed
Send feedback